Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of lysine, hydroxylysine, and/or tryptophan.
No clinical trials have been registered for inborn disorder of lysine, hydroxylysine, and tryptophan metabolism.
3 publications have been identified in PubMed for inborn disorder of lysine, hydroxylysine, and tryptophan metabolism. Research spans Review / Meta-Analysis (67%) and Case Report / Case Series (33%).
Gragnaniello V (2025). [PMID: 40361251](https://pubmed.ncbi.nlm.nih.gov/40361251/). *Ital J Pediatr*. [Case Report / Case Series]
Tarr JD (2025). [PMID: 39953653](https://pubmed.ncbi.nlm.nih.gov/39953653/). *J Inherit Metab Dis*. [Review / Meta-Analysis]
Gemici Karaaslan B (2025). [PMID: 39957310](https://pubmed.ncbi.nlm.nih.gov/39957310/). *J Inherit Metab Dis*. [Review / Meta-Analysis]
Data assembled from 2 of 12 sources · Last updated Sep 21, 2026, 4:54 AM UTC